Twist Bioscience
Stock Forecast, Prediction & Price Target
Twist Bioscience Financial Estimates
Twist Bioscience Revenue Estimates
Twist Bioscience EBITDA Estimates
Twist Bioscience Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2026 | 9/30/2027 | 9/30/2028 | |
Revenue
% change YoY
| $203.56M N/A | $245.10M 20.40% | $312.97M 27.68% | Avg: $436.61M Low: $426.39M High: $452.68M avg. 39.50% | Avg: $515.9M Low: $503.82M High: $534.89M avg. 18.15% | Avg: $597.5M Low: $583.51M High: $619.49M avg. 15.81% | |
Net Income
% change YoY
| $-217.86M N/A | $-204.61M 6.07% | $-208.72M -2.00% | Avg: $-103.21M Low: $-142.21M High: $-77.93M avg. 50.55% | Avg: $-98.97M Low: $-103.71M High: $-95.96M avg. 4.10% | Avg: $-65.98M Low: $-69.14M High: $-63.97M avg. 33.33% | |
EBITDA
% change YoY
| $-247.04M N/A | $-174.15M 29.50% | $-176.70M -1.46% | Avg: $-418.12M Low: $-433.51M High: $-408.33M avg. -136.62% | Avg: $-494.05M Low: $-512.23M High: $-482.48M avg. -18.15% | Avg: $-572.19M Low: $-593.26M High: $-558.79M avg. -15.81% | |
EPS
% change YoY
| -$4.04 N/A | -$3.6 10.89% | -$3.6 0% | Avg: -$2.04 Low: -$2.5 High: -$1.37 avg. 43.47% | Avg: -$1.74 Low: -$1.82 High: -$1.69 avg. 14.49% | Avg: -$1.16 Low: -$1.22 High: -$1.12 avg. 33.33% | |
Operating Expenses
% change YoY
| $333.25M N/A | $306.88M -7.91% | $354.18M 15.41% | Avg: $477.35M Low: $466.18M High: $494.93M avg. 34.77% | Avg: $564.04M Low: $550.83M High: $584.81M avg. 18.15% | Avg: $653.25M Low: $637.96M High: $677.30M avg. 15.81% | |
FAQ
What is Twist Bioscience stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 29.32% in 2026-2028.
We have gathered data from 4 analysts. Their low estimate is -142.21M, average is -103.21M and high is -77.93M.
What is Twist Bioscience stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.49% in 2026-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $426.39M, average is $436.61M and high is $452.68M.
What is Twist Bioscience stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 30.43% in 2026-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.5, average is -$2.04 and high is $-1.37.
What is the best performing analyst?
In the last twelve months analysts have been covering Twist Bioscience stock. The most successful analyst is Subbu Nambi.